Genova Acquires Metametrix to Expand Laboratory Testing Services
Diagnostic testing services firm Genova Diagnostics acquired Metametrix to generate a combined entity with a broader range of laboratory testing services. The firms will continue to operate under both brands. “Consolidating our companies significantly increases our global presence,” comments Ted Hull, chairman and CEO at Genova. “Our combined resources will allow us to expand investments in R&D, clinical trials, medical education, and market expansion.” The two firms in combination have 400 employees and operate in 45 countries through its three facilities in the U.S. and U.K.
Metametrix specializes in the provision of clinical laboratory services in the area of nutrients, toxicants, hormonal balance, biotransformation and detoxification, gastrointestinal function, and the microbiome.The firm is in addition working to develop next-generation testing capabilities that will help tailor treatment options for chronic diseases such as cardiovascular, gastrointestinal, inflammatory, mental/emotional, and autism spectrum disorders.
Established in 1986, specialty clinical laboratory Genova offers over 125 specialized diagnostic and genomic-based tests in a wide range of physiological fields including digestive, immunology, metabolic function and endocrinology.